Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000151329 | SCV000199299 | benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | Arg1466Trp in Exon 32 of MYH9: This variant is not expected to have clinical sig nificance because it has been identified in 0.5% (35/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs139134727). |
Eurofins Ntd Llc |
RCV000726552 | SCV000345457 | uncertain significance | not provided | 2016-09-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000293752 | SCV000438346 | benign | MYH9-related disorder | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000348717 | SCV000438347 | likely benign | Autosomal dominant nonsyndromic hearing loss 17 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Gene |
RCV000726552 | SCV000589345 | likely benign | not provided | 2021-05-25 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26343384, 29090586) |
Invitae | RCV000726552 | SCV001036430 | likely benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000151329 | SCV002070855 | uncertain significance | not specified | 2019-05-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003927454 | SCV004750680 | likely benign | MYH9-related condition | 2019-07-16 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV000726552 | SCV001741519 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000726552 | SCV001932835 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000726552 | SCV001966404 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000726552 | SCV002035927 | likely benign | not provided | no assertion criteria provided | clinical testing |